Posted in Business, Pharma, Pharmaceutical, tagged Outsourcing on October 19, 2007 | 2 Comments »
You’re not good at something (either as an individual, or as a department). You have limited time and resources. And you have a simple choice:
Try to do it badly. Or let someone else do it.
Letting someone else do it is often a very wise idea. It’s usually called outsourcing (a couple years back, I had [...]
Posted in After Hours, Fun on October 19, 2007 | No Comments »
Breathtaking image of a lunar eclipse.
Plants are apparently far more complex than we thought. First, they “talk” to one another. Now we find out that one plant species absorbed the lessons of Arsenic and Old Lace and poisons its neighbors with acid! And finally, Pinot Noir grapes are genetically more complex than we are!
Why didn’t [...]
Posted in Sales training, Training, tagged Karl Kapp, Mid-NJ ASTD, Serious Gaming, Simulations on October 19, 2007 | No Comments »
Here are 17 excellent reasons to measure (assess/evaluate) learning, from Will Thalheimer’s blog.
Upcoming event for those in the NJ/Philly/NY area - the 2nd Annual Technology Showcase, sponsored by the Mid-NJ ASTD chapter. This is scheduled for November 15. There will be a keynote, a series of short presentations, a sit-down dinner, and a great collection [...]
Posted in Pharma, Pharmaceutical, Sales training, Webinar on October 19, 2007 | No Comments »
A few resources that might be of interest to my pharma/sales training audience:
Very cool medical animation of blood flow (from the ever-interesting Kevin, M.D. blog)
Upcoming free webinar (Oct. 23) on Sales Coaching for better Sales Results (featuring Linda Richardson). And, on the same day, an ASTD webcast on Learning and Social Networks (take [...]
Posted in Amylin, Avandia, Bayer, Biotech, GSK, Genentech, Genzyme, Glaxosmithkline, J&J, Johnson and Johnson, Lilly, Medical Devices, Merck, News, Novartis, Pharma, Pharma News, Pharmaceutical, Wyeth, tagged Avandia, Boston Scientific, Byetta, Doribax, Exubera, InVentiv Health, Isentress, Ixempra, Januvia, Lexiva on October 19, 2007 | 2 Comments »
The Good Stuff:
BMS gets approval for new oncology drug (for breast cancer) Ixempra.
Merck gets new HIV drug (Isentress) approved in the U.S. And, their Januvia diabetes drug gets new uses approved.
Abraxis gets cancer drugs approved.
J&J gets Doribax (for intra-abdominal and urinary tract infections) approved.
Bayer reports upbeat MS drug results.
Glaxo: new use of HIV drug Lexiva [...]
Posted in Pharma, Pharma News, Pharmaceutical, tagged Altace, downsize, job cuts, King pharmaceuticals on October 19, 2007 | No Comments »
King Pharmaceuticals has suffered a setback (potential generic competitors for Altace), and will be cutting its employee base significantly.
That’s the straightforward way to say it. But when companies have to make cuts, you can be sure that the most creative use of obfuscation will come to the fore. Here’s the headline announcing this:
King Pharmaceuticals Accelerates [...]
Posted in After Hours, Fun, tagged AT&T, snow, winter on October 11, 2007 | No Comments »
I saw this fascinating microscopic picture of a snowflake - absolutely mind-blowing. That got me on a kick to find others: here, here, here, here, here, here, here, here. Amazing.
More winter (I know, it’s barely fall!) - the dramatic effects of a Swiss ice storm.
After several months of absence in the on-line video world, this [...]
Posted in FDA, GSK, Glaxosmithkline, Marketing, Merck, Pharma News, Pharmaceutical, Sanofi-Aventis, Wyeth, tagged Actonel, BI, IMS, statin, Teva on October 11, 2007 | No Comments »
Can an old antibiotic be used to reduce stroke damage? Fascinating potential resurrection/re-purposing of an older drug.
Glaxo announces its succession plan at the top: new CEO named.
Merck gets a high rating from primary care physicians.
Teva gets a go-ahead for generic Actonel.
From the rumor mill…Pfizer looking over Sanofi??
Wyeth going after the hot flash market.
IMS data screw-up [...]
Posted in Business, Reviews, tagged book review, harry paul, leadership, management, revved, ross reck on October 9, 2007 | No Comments »
I will begin this book review with a confession - I have been negligent.
One of the co-authors of this book kindly forwarded me a copy months ago, and it sat on my “To Read” pile for far too long. A couple weeks back, I determined to read it. And a quick read it was.
This book [...]
Posted in Business, Friday Collection, Marketing, Pharma, Pharmaceutical, Sales, tagged drug reps on October 5, 2007 | 3 Comments »
This post is meant to promote discussion. I’m not going to presume to think that I have anything close to all the answers. But a discussion needs to take place about the current sales model in pharma.
It’s common knowledge that the current pharmaceutical sales force model is inefficient, expensive, and poorly designed to meet current [...]
